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Abstract
Although psychiatric disorders are classified as non-communicable diseases, we believe this 
classification is too rigid and limiting. We present evidence of the communicability of psychiatric 
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disorders through three major pathways: infectious and ecological, familial, and sociocultural 
communicability. Successful strategies developed to control the spread of communicable 
infectious diseases are relevant to curtailing the communicability of psychiatric disorders, thereby 
reducing their burden. Current interventions and policies that conceptualise psychiatric illnesses as 
non-communicable mostly focus on the individual. By applying strategies from infectious disease 
and chronic illness prevention models within a socioecological framework, we posit a broad 
communicable chronic disease psychiatric illness control plan for effectively treating the patient 
with the psychiatric disorder (host) as early as possible, providing benefits to their family and the 
community, and preventing transmission to others.
Introduction
WHO defines communicable diseases as those caused by infectious agents or their toxic 
products directly or indirectly transmitted from person to person, from animal to person, and 
from the environment to person (eg, through food, air, water, body fluids).1 We believe that 
well established strategies developed to contain the spread of infectious diseases could be 
successfully applied to other illnesses that are transmitted from one person to another (either 
directly or through the indirect pathways noted above).
This Personal View examines how substance use and other mental health illnesses can be 
communicated through three major pathways.
Evidence for the communicable nature of psychiatric disorders
Infectious and ecological communicability
Pathogens and microorganisms that invade the brain can directly affect organ function, 
causing delirium, psychosis, mania, and depression.2–5
The brain–gut axis and the microbiome can interfere with fermentation processes in the 
intestinal flora that produce fatty acids such as butyrate, which is a neuropsychiatric 
regulator.6 Shifts in the gut microbiome, due to changes in diet or as a response to stress,7 
can manifest as depression8 and post-traumatic stress disorder.9
Exposure to environmental factors such as toxins (eg, lead, tobacco) or contaminated water 
sources put children at an increased risk of later developmental and psychiatric disorders.10 
Urbanicity is associated with an increased risk of psychosis, possibly related to individual-
level environmental exposure to cannabis use, social adversity, exclusion, and 
discrimination.11 Similar to man-made disasters,11,12 natural disasters are associated with 
psychiatric illness, including depressive, anxiety, and post-traumatic stress disorders.12
Familial communicability
Risks associated with having family members with psychiatric illness are multifaceted, 
including genetic, behavioural, prenatal and perinatal, and developmental pathways.
Whereas low-prevalence disorders such as schizophrenia (1–3% prevalence worldwide) and 
autism (1–2% prevalence) are highly heritable (0·70 heritability for schizophrenia13 and 
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0·64–0·91 for autism14), more common disorders such as depression (4·67% prevalence) and 
anxiety (7·30% prevalence) have lower heritability (0·37–0·67 for depression and 0·32–0·49 
for anxiety15). Substance use disorders have a worldwide prevalence of 6·8% and an 
estimated heritability as high as 0·50.16 The established genetic basis of most psychiatric 
disorders17 cannot explain the increased prevalence of psychiatric disorders among family 
members with no genetic relationship, such as spouses, and it cannot explain the adverse 
effects of psychiatric disorders on family members who do not have psychiatric illness.18
Assortative mating is the non-random mating pattern of people with specific attributes. This 
mating pattern might augment existing shared traits, behaviours, and life circumstances, 
which can explain why psychiatric disorders are highly heritable when they are associated 
with reduced fecundity, why some disorders are more highly heritable than others, and the 
genetic comorbidity across psychiatric disorders.19 Assortative mating between people with 
psychiatric illness could lead to increased communicability within families through both 
genetic and nurturing influences.20
Perinatal and parenting-related patterns also have a role in familial communicability. A 
psychiatric disorder within a family is associated with poorer mental health in offspring than 
in families who do not have a psychiatric disorder. Aside from genetics, this association 
could be attributed to exposure to stress at multiple levels21 (ie, biological, behavioural, 
socioeconomic) during developmentally formative years. In addition, maternal depression is 
associated with adverse outcomes in the fetus, infant, and child.22,23 Brain development 
begins in utero, and is influenced by maternal stress, anxiety and depression, and the toxic 
effects of alcohol and other substances, which all have negative effects on 
neurodevelopment.22,24–26 Postnatal maternal anxiety and depression affect early 
development and mental health, possibly through changes in maternal behaviours such as 
caressing the infant27 and provision of support28—crucial factors in the development of 
stress and emotion regulation systems during infancy. Maternal depression, anxiety, and 
stress are shown to be bidirectionally associated with offspring depression and experiences 
of stress.29 Symptoms of post-traumatic distress have been shown to affect the psychiatric 
disorders of those close to the patient with post-traumatic distress.30 Both maternal stress 
specifically, and parental psychopathology generally, have been shown to be associated with 
the psychiatric health of children.31,32 Living with a relative with a psychiatric disorder as a 
young child can be an adverse childhood event.33 Substance use disorders are a powerful 
risk factor for household dysfunction, abuse and neglect, and placement into alternative 
living arrangements such as foster care.33
Epigenetic patterns are caused by molecular alterations (eg, DNA methylation, microRNA 
expression, and histone modifications) that can turn genes on or off selectively. They change 
in association with stress and the family nurturing environment34–36 Altered epigenetic 
regulation can explain some of the intergenerational and intrafamilial correlation, including 
endocrine and brain development. Alterations of gene expression due to stress exposure can 
also contribute to clustering of psychiatric illness, termed transgenerational epigenetic 
inheritance,34 and can begin during intrauterine development, emphasising once more the 
crucial role of mothers in the communicability of psychiatric diseases. A 9-year follow-up 
study of a birth cohort in 20 large American cities (n=2420) showed that children with father 
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loss have significant epigenetic changes—shorter telomeres. Paternal death had the largest 
association with shorter telomeres; interestingly, when fathers were lost due to separation or 
divorce, loss of telomere length was greatly mediated by loss of income. However, loss of 
income had a less substantial contribution to loss of telomere length when fathers were lost 
due to death or incarceration, emphasising the role of fathers beyond provision of tangible 
goods and the strong negative effects of parental incarceration.37
Sociocultural communicability
In addition to the well described social determinants, including social inequities, ongoing 
racism, discrimination, and physical health disparities,38,39 psychiatric illnesses show a 
pattern of transmission within cultures40 and social networks,41 particularly in young 
people.42
Poverty, famine, social disadvantage, and structural discrimination are common risk factors 
for psychiatric illness.10,38 Natural12 and man-made disasters increase the prevalence of 
psychiatric illness and can have long-term and intergenerational effects. Many so-called 
epidemics of psychiatric illness have been recorded in areas afflicted by ongoing armed 
conflict and forced migration,43 terrorist attacks,44 and financial crises.45 Rape, female 
genital mutilation, societal restrictions, and violence directed at girls and women are 
associated with adverse psychiatric consequences.46,47 Among the lesbian, gay, bisexual, 
and transgender (LGBT) population, prejudice and stigma—from self, family, and 
community institutions, in addition to discrimination, childhood abuse, sexual victimisation, 
and harsh criminal prosecution—might account for some of the enhanced risk for poor 
mental health.48–52 Indeed, any minority identity—eg, historically colonised Indigenous 
populations—can have a heightened risk of collective generational and lifespan traumas, 
increased vulnerability to multiple lifetime disorders (through pathways of childhood 
adversity and negative family environments), and collective generational adversity.39
Substance use disorders are the most prevalent and burdensome example53 of a psychiatric 
disorder arising from institutional culture, with both a familial54 and a social pattern of 
communicability, particularly when use occurs as part of the institutional culture observed in 
correctional facilities, schools, and colleges.55 The diversity of pathways in the initiation of 
so-called gateway substances (ie, tobacco, alcohol, cannabis) and how this initial substance 
use can progress to use of other illicit drugs provides evidence for communicability.56
Suicide clusters57 have been described in various institutional and community contexts, 
suggesting a substantial social contagion effect, particularly in young people.42 Proposed 
underlying mechanisms have included direct transmission, imitation, common context, and 
affiliation.57 Mass psychogenic illness has been reported globally from North America58 to 
Africa59 and southeast Asia.60 Symptoms are often attributed to witchcraft61 or 
environmental toxicity,58 but can be evoked in psychology laboratory settings.62 Culture-
bound syndromes, such as koro (an anxiety disorder associated with the fear that one’s 
genitals are shrinking), also appear in clusters, suggesting transmission.40
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Addressing the communicability of psychiatric illness
We believe that successful strategies developed to control the spread of communicable 
infectious diseases are relevant to curtailing the communicability of psychiatric disorders, 
thereby reducing their burden. Interventions and policies that conceptualise psychiatric 
illnesses as non-communicable mostly focus on the individual. By applying strategies from 
infectious disease63 and chronic illness prevention models64 within a socioecological 
framework,65 we suggest a broad communicable chronic disease psychiatric illness control 
plan (figure) to effectively treat the psychiatric patient (host) as early as possible and prevent 
transmission to others.
At the individual level
Undiagnosed patients with psychiatric disorders, and patients at risk of these disorders, 
should be identified by integrating routine (self-administered or easy to administer), state-of-
the-art, multilevel validated screenings (including household assessments and, eventually, 
biological testing) into primary care and the community, through public health strategies 
across urban, suburban, and rural settings.
Linking to care, and treating and retaining in care, patients who have a positive screen for 
psychiatric illness should be prioritised, as is facilitating adherence to maximise treatment 
outcomes, reduce disability, and prevent further transmission by using evidence-informed 
treatment as prevention.
At the family level
Intervention and prevention strategies should be developed, targeting people at a high-risk of 
developing psychiatric disorders, including first-degree relatives and household members of 
patients with psychiatric illness.
Intervention and prevention strategies targeting those whose psychiatric disorders will 
impact others, including parents and other caregivers of children, should be implemented. 
Keeping such people free of, or in remission from, psychiatric disorders can be expected to 
reduce the risk of communicability.
At the community and systems level
Awareness and prevention strategies should be promoted, within and beyond the health 
system, including overall communities and their specific constituents: families, schools, 
hospitals, churches, jails, and the armed forces. Structural interventions to maximise salutary 
psychiatric outcomes should be applied, including psychosocial support, prevention of 
interpersonal violence, discrimination, bullying, and traumatic brain injuries, organisation of 
community youth activities, and implementation of effective alcohol and substance misuse 
policies. Such interventions would increase knowledge, reduce incidence and burden, 
decrease stigma and social isolation, reduce barriers to care, and, for individuals with the 
most severe psychiatric disorders, provide opportunities for employment and housing.
Surveillance, identification, and early intervention should be prioritised for specific 
communities at a high risk of developing psychiatric disorders. Communities that would 
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benefit from this strategy include conflict zones, high crime and low-resourced 
neighbourhoods, areas affected by natural disasters and those affected by epidemics of 
substance use, psychogenic illness, and suicide cluster incidence.
This novel framework applies successful strategies developed to control the spread of 
communicable infectious diseases to curtail the communicability of psychiatric disorders 
and reduce their burden. Implementing multiple interventions—some of them already in use
—within public systems of care, would offer an efficient way of utilising resources, 
particularly important in low-resource settings, to reduce the communicability and chronic 
occurrence of psychiatric disorders. Although a few countries have recognised the need to 
scale up mental health services using some of these strategies for various disorders,66–68 and 
some funding agencies have allocated monies to address the global mental health treatment 
gap,69 the comprehensive approach described here is yet to be implemented. An ongoing 
hybrid cost-effectiveness and implementation scale-up study in Mozambique will provide 
evidence regarding this framework (NCT03610750).
Even though psychiatric disorders are the leading cause of years lost to disability globally70 
and are estimated to account for more than half of the projected total economic burden from 
non-communicable diseases by 2030,71 on average, only 0·5% (in low-income and middle-
income countries) to 5·1% (in high-income countries) of national health-care budgets have 
been devoted to mental health disorders.72 In contrast, low-income and middle-income 
countries affected by the HIV epidemic have instituted multiple approaches to eradicate this 
epidemic, combining local and global funding. Global funding for infectious diseases and 
non-psychiatric non-communicable diseases are, respectively, 17 times and four times higher 
than funds targeted to mental health disorders.73,74 Classifying diseases as either 
communicable or non-communicable might create conceptual barriers to effective public 
health strategies and skew funding priorities. The little funding available for psychiatric 
illness typically facilitates intervention at the individual level. Funding for interventions at 
the family level, to address the communicability embedded in the mother–child dyad, should 
target integration of psychiatric services into care for women and children63 as a feasible, 
cost-effective way of delivering services and curtailing communicability. Substance misuse 
and domestic violence would be other important targets of intervention at the family level. 
Community gateways, such as schools and primary care with community health workers, 
family-oriented centres and associations, and hospitals, should have staff trained in the 
delivery of family-level and community-level strategies, enlisting medical, psychiatric, and 
social welfare professionals, along with community and social leaders. Policy reform and 
collaboration with governments and legal systems are needed to implement this framework. 
A shift from a purely non-communicable disease approach, to incorporating communicable 
disease strategies for psychiatric illnesses would enable families, networks, and communities 
to mobilise resources and integrate treatment into care systems aimed at psychiatric illness 
awareness and prevention.
One of the arguments against developing a stronger focus on expanding efforts to treat 
mental illnesses in resource-limited environments is that health-care systems are already 
overburdened and imposing additional tasks is unrealistic, especially without an expansion 
of the health-care workforce. However, we believe that our approach will lessen the burden 
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on the health-care system. The communicable chronic disease psychiatric illness control 
plan must first be reviewed to determine where it will be implemented, who will be 
responsible for each phase, and the best methods to train those who will carry it out and 
monitor and sustain its implementation.
The brain and the body function as an integrated system, but the care system for conditions 
affecting the brain and body usually operates in silos. Stigma about mental illness, which 
pervades the education of all health-care providers, creates the belief that treating mental 
illnesses can be avoided through triage to specialists. In practice, people with common 
mental health disorders routinely present to medical providers with somatic complaints such 
as those seen in anxiety disorders (eg, palpitations, shortness of breath, gastrointestinal 
problems) and depressive disorders (eg, fatigue and pain). Failure to diagnose and treat 
psychiatric disorders results in multiple futile medical visits. Recognising that the brain and 
the body are one system, and that diseases can be both chronic and communicable, creates 
the unity we need to better improve the health of all populations.
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